Back to search

A double-blind, randomized, placebo-controlled study to assess the safety and efficacy of nebulized PC945 when added tosystemic antifungal therapy for the treatment of refractory invasive pulmonary aspergillosis (OPERA-T Study)

Date:

07/01/2024

Lead Investigators:

Summary

No summary available